How does nephritic syndrome differ from acute kidney injury regarding clinical presentation, laboratory findings, and management?

Nephritic Syndrome vs AKI: Key Distinctions

Nephritic syndrome and AKI are fundamentally different entities—nephritic syndrome is a specific glomerular disease characterized by hematuria, proteinuria, hypertension, and often AKI as a complication, while AKI is a functional diagnosis defined by acute decline in kidney function (rise in creatinine ≥0.3 mg/dL within 48 hours or ≥50% within 7 days) that can result from multiple causes including nephritic syndrome itself 1, 2.

Core Conceptual Difference

Nephritic syndrome is a disease; AKI is a functional state. Nephritic syndrome represents active glomerular inflammation with specific clinical features, whereas AKI describes an acute functional decline in kidney performance from any cause 3.

Clinical Presentation

Nephritic Syndrome Features:

• Hematuria is universal—specifically microscopic hematuria with dysmorphic red blood cells and red cell casts 3, 4
• Moderate proteinuria (typically 1-3 g/day, not nephrotic-range)
• Hypertension is characteristic
• Edema from salt and water retention
• May or may not have AKI at presentation
• Specific diseases: post-infectious glomerulonephritis, IgA nephropathy, lupus nephritis, ANCA-associated vasculitis 3

AKI Features:

• Defined purely by functional criteria 1, 2:
  • Serum creatinine increase ≥0.3 mg/dL within 48 hours, OR
  • Serum creatinine increase ≥50% within 7 days, OR
  • Urine output <0.5 mL/kg/h for 6 hours
• No specific urine sediment requirement
• Can occur with or without hematuria
• Multiple etiologies: pre-renal (hypovolemia), intrinsic (tubular necrosis, glomerulonephritis), post-renal (obstruction)

Laboratory Findings

Nephritic Syndrome:

• Active urine sediment: dysmorphic RBCs, RBC casts, WBC casts
• Moderate proteinuria (not nephrotic-range)
• Decreased GFR is common (occurs in 20-30% of cases) 4
• Elevated inflammatory markers (C-reactive protein)
• Serologic markers depending on etiology: low C3/C4 (post-infectious, lupus), positive ANCA (vasculitis), positive anti-GBM antibodies 5
• Anemia may develop 4

AKI (without nephritic syndrome):

• Elevated creatinine by definition
• Urine sediment varies by cause:
  • Bland sediment in pre-renal AKI
  • Muddy brown casts in acute tubular necrosis
  • Active sediment only if glomerulonephritis is the cause
• FeNa helps differentiate: <1% suggests pre-renal; >2% suggests intrinsic 6
• No specific serologic pattern

Critical Diagnostic Pitfall

Nephritic syndrome frequently causes AKI 3. When you see active urine sediment (RBC casts, dysmorphic RBCs) with AKI, you're dealing with nephritic syndrome causing AKI, not simple AKI. The presence of RBC casts is pathognomonic for glomerulonephritis and mandates evaluation for nephritic syndrome.

Management Approach

For Nephritic Syndrome:

1. Urgent serologic workup: ANCA, anti-GBM, complement levels, ANA 5
2. Do not delay immunosuppression if ANCA or anti-GBM positive with compatible presentation—start treatment before biopsy results if patient is deteriorating 5
3. Kidney biopsy is gold standard (diagnostic yield 91.5% in GPA) but shouldn't delay treatment in rapidly progressive cases 5
4. Specific immunosuppression based on underlying disease (steroids, cyclophosphamide, rituximab for ANCA vasculitis)
5. Blood pressure control is essential
6. Monitor for pulmonary-renal syndrome—simultaneous lung and kidney injury suggests vasculitis requiring urgent plasma exchange if anti-GBM positive 5

For AKI (non-glomerular):

1. Identify and remove precipitants: nephrotoxic drugs, hypovolemia, obstruction 1
2. Optimize hemodynamics: fluid resuscitation if pre-renal; avoid fluid overload if intrinsic 1
3. Supportive care: no specific therapies for most causes
4. Monitor for complications: hyperkalemia, acidosis, uremia
5. Consider RRT if severe (stage 3 with complications)
6. Avoid nephrotoxins: NSAIDs, aminoglycosides, contrast 1

Specific Clinical Scenarios

Nephrotic Syndrome Developing AKI:

This is a distinct scenario where nephrotic syndrome (heavy proteinuria >3.5 g/day, hypoalbuminemia, edema) develops AKI as a complication 7, 8. Risk factors include:

• Severe hypoalbuminemia (≤24 g/L)
• Diuretic-induced hypovolemia 9
• Nephrotoxic drug exposure 7
• Infection 7, 10
• Renal vein thrombosis

Management: Treat underlying nephrotic syndrome, avoid aggressive diuresis, maintain adequate perfusion, address infections promptly 9.

Prognosis and Outcomes

• Nephritic syndrome: Prognosis depends on underlying disease; ANCA vasculitis has 40-70% mortality if severe 2; post-infectious GN usually recovers
• AKI: Associated with increased mortality (40-70% in critically ill) and progression to CKD even with recovery 2, 11
• Persistent AKI beyond 48 hours has worse outcomes than rapid reversal 11
• AKI lasting 7-90 days is termed Acute Kidney Disease (AKD) and represents a continuum toward CKD 11